4mg 2ml Dexamethason Sodium Phosphate Injection

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
  • 4mg 2ml Dexamethason Sodium Phosphate Injection
Find Similar Products

Basic Info.

Model NO.
AMC14010-01
Suitable for
Adult
State
Liquid
Shape
Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Transport Package
10′s/Box
Specification
4mg/1ml, 10′s/box
Trademark
MEDIPHARM/OEM
Origin
China
HS Code
3004909099
Production Capacity
90000box/Per Month

Product Description

Product Description

Product Description

4mg 2ml Dexamethason Sodium Phosphate Injection

Indications:
Conditions: where the anti inflammatory and immunosuppressive effects of a corticosteroid are desirable, including intensive treatment during shorter periods.
Contra-Indications:
Sensitive to corticosteroids, Tuberculosis, Ocular herpes simplex, Primary glaucoma. Acute psychosis and psychoneurosis, Systemic infection, Peptic ulcer, Osteoporosis.
Warning:
Dxms  phosphate Injection should not be administered intrathecally or subconjunctivally. Toxic effects may result from withdrawal or from continued use of large doses. Dxms  phosphate should be used with extreme caution in the presence of congestive heart failure, hypertension, in patients with diabetes mellitus, infectious diseases, chronic renal failure, uraemia and in elderly patients.
Dosage and indications for use.:
Usual adult dosage ranges from 0,5 to 20 mg daily depending on the severity of the disorder. Dxms phosphate may be administered intravenously or intramuscularly. The parenteral administration must be re
Dexamethason served for administration in emergencies or ad intensive therapy. Intra-articular, intralesional intra-muscular or soft-tissue injection: 0,8 to 4mg (depending on the size of the joint).
Storage:
Store below 25ºC. Protect from light. Keep out of reach of children. 

 

4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection
4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection4mg 2ml Dexamethason Sodium Phosphate Injection

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier